Lentivirus vectors are presently the favorite vehicles for therapeutic gene transfer in hematopoietic cells. Nonetheless, these vectors integrate randomly throughout the genome, exhibiting variegation of transgene expression due to the spreading of heterochromatin into the vector sequences. Moreover, the cis-regulatory elements harbored by the vector could disturb the proper transcription of resident genes neighboring the integration site. The incorporation of chromatin insulators in flanking position to the transferred unit can alleviate both the above-mentioned dangerous effects, due to the insulator-specific barrier and enhancer-blocking activities. In this study, we report the valuable properties of the sea urchin-derived sns5 insulator in improving the expression efficiency of a lentivirus vector integrated in the mammalian erythroid genome. We show that these results neither reflect an intrinsic sns5 enhancer activity nor rely on the recruitment of the erythroid-specific GATA-1 factor to sns5. Furthermore, by using the Chromosome Conformation Capture technology, we report that a single copy of the sns5-insulated vector is specifically organized into an independent chromatin loop at the provirus locus. Our results not only provide new clues concerning the molecular mechanism of sns5 function in the erythroid genome but also reassure the use of sns5 to improve the performance of gene therapy vectors.
Get full access to this article
View all access options for this article.
References
1.
HenikoffS. (1990). Position-effect variegation after 60 years. Trends Genet, 6:422–426.
2.
ClarkAJ, BissingerP, BullockDW, DamakS, WallaceR, WhitelawCB and YullF. (1994). Chromosomal position effects and the modulation of transgene expression. Reprod Fertil Dev, 6:589–598.
3.
KarpenGH. (1994). Position-effect variegation and the new biology of heterochromatin. Curr Opin Genet Dev, 4:281–291.
4.
EmeryDW and StamatoyannopoulosG. (1999). Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress. Ann N Y Acad Sci, 872:94–107.
5.
PannellD and EllisJ. (2001). Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol, 11:205–217.
6.
EllisJ. (2005). Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther, 16:1241–1246.
7.
GasznerM and FelsenfeldG. (2006). Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet, 7:703–713.
8.
RamunasJ, MontgomeryHJ, KellyL, SukonnikT, EllisJ, and JervisEJ. (2007). Real-time fluorescence tracking of dynamic transgene variegation in stem cells. Mol Ther, 15:810–817.
9.
RaabJR and KamakakaRT. (2010). Insulators and promoters: closer than we think. Nat Rev Genet, 11:439–446.
10.
Recillas-TargaF, PikaartMJ, Burgess-BeusseB, BellAC, LittMD, WestAG, GasznerM and FelsenfeldG. (2002). Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci U S A, 99:6883–6888.
11.
MutskovVJ, FarrellCM, WadePA, WolffeAP and FelsenfeldG. (2002). The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation. Genes Dev, 16:1540–1554.
12.
MutskovV and FelsenfeldG. (2004). Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J, 23:138–149.
13.
NienhuisAW, DunbarCE and SorrentinoBP. (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther, 13:1031–1049.
14.
NaldiniL. (2011). Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet, 12:301–315.
15.
RivièreI, DunbarCE and SadelainM. (2012). Hematopoietic stem cell engineering at a crossroads. Blood, 119:1107–1116.
16.
De PalmaM, MontiniE, Santoni de SioFR, BenedicentiF, GentileA, MedicoE and NaldiniL. (2005). Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood, 105:2307–2315.
17.
ModlichU, BohneJ, SchmidtM, von KalleC, KnössS, SchambachA and BaumC. (2006). Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood, 108:2545–2553.
18.
MontiniE, CesanaD, SchmidtM, SanvitoF, PonzoniM, BartholomaeC, Sergi SergiL, BenedicentiF, AmbrosiA, et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol, 24:687–696.
19.
CattoglioC, FacchiniG, SartoriD, AntonelliA, MiccioA, CassaniB, SchmidtM, von KalleC, HoweS, et al. (2007). Hot spots of retroviral integration in human CD341 hematopoietic cells. Blood, 110:1770–1778.
20.
HemattiP, HongBK, FergusonC, AdlerR, HanawaH, SellersS, HoltIE, EckfeldtCE, SharmaY, et al. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol, 2:e423.
21.
MontiniE, CesanaD, SchmidtM, SanvitoF, BartholomaeCC, RanzaniM, BenedicentiF, SergiLS, AmbrosiA, et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest, 119:964–975.
22.
BokhovenM, StephenSL, KnightS, GeversEF, RobinsonIC, TakeuchiY and CollinsMK. (2009). Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol, 83:283–294.
23.
EscorsD and BreckpotK. (2010). Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp, 58:107–119.
24.
EmeryDW. (2011). The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum Gene Ther, 22:761–774.
25.
AntoniouMN, SkipperKA and AnakokO. (2013). Optimizing retroviral gene expression for effective therapies. Hum Gene Ther, 24:363–374.
26.
GrothAC, LiuM, WangH, LovelettE and EmeryDW. (2013). Identification and characterization of enhancer-blocking insulators to reduce retroviral vector genotoxicity. PLoS One, 8:e76528.
27.
LiuM, MauranoMT, WangH, QiH, SongCZ, NavasPA, EmeryDW, StamatoyannopoulosJA and StamatoyannopoulosG. (2015). Genomic discovery of potent chromatin insulators for human gene therapy. Nat Biotechnol, 33:198–203.
28.
StiefA, WinterDM, SträtlingWH and SippelAE. (1989). A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature, 341:343–345.
29.
BoniferC, VidalM, GrosveldF and SippelAE. (1990). Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J, 9:2843–2848.
30.
KellumR and SchedlP. (1991). A position-effect assay for boundaries of higher order chromosomal domains. Cell, 64:941–950.
31.
HegerP and WieheT. (2014). New tools in the box: an evolutionary synopsis of chromatin insulators. Trends Genet, 30:161–171.
32.
MatzatLH and LeiEP. (2014). Surviving an identity crisis: a revised view of chromatin insulators in the genomics era. Biochem Biophys Acta, 1839:203–214.
33.
BartkuhnM, StraubT, HeroldM, HerrmannM, RathkeC, SaumweberH, GilfillanGD, BeckerPB and RenkawitzR. (2009). Active promoters and insulators are marked by the centrosomal protein 190. EMBO J, 28:877–888.
34.
BusheyAM, RamosE and CorcesVG. (2009). Three subclasses of a Drosophila insulator show distinct and cell type-specific genomic distributions. Genes Dev, 23:1338–1350.
35.
NegreN, BrownCD, ShahPK, KheradpourP, MorrisonCA, HenikoffJG, FengX, AhmadK, RussellS, et al. (2010). A comprehensive map of insulator elements for the Drosophila genome. PLoS Genet, 6:e1000814.
36.
DixonJR, SelvarajS, YueF, KimA, LiY, ShenY, HuM, LiuJS and RenB. (2012). Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature, 485:376–380.
37.
SextonT, YaffeE, KenigsbergE, BantigniesF, LeblancB, HoichmanM, ParrinelloH, TanayA and CavalliG. (2012). Three-dimensional folding and functional organization principles of the Drosophila genome. Cell, 148:458–472.
38.
PallaF, MelfiR, AnelloL, Di BernardoM and SpinelliG. (1997). Enhancer blocking activity located near the 3′ end of the sea urchin early H2A histone gene. Proc Natl Acad Sci U S A, 94:2272–2277.
39.
CavalieriV, MelfiR and SpinelliG. (2009). Promoter activity of the sea urchin (Paracentrotus lividus) nucleosomal H3 and H2A and linker H1 α-histone genes is modulated by enhancer and chromatin insulator. Nucleic Acids Res, 37:7407–7415.
40.
CavalieriV, MelfiR and SpinelliG. (2013). The Compass-like locus, exclusive to the Ambulacrarians, encodes a chromatin insulator binding protein in the sea urchin embryo. PLoS Genet, 9:e1003847.
41.
MelfiR, PallaF, Di SimoneP, AlessandroC, CalìL, AnelloL and SpinelliG. (2000). Functional characterization of the enhancer blocking element of the sea urchin early histone gene cluster reveals insulator properties and three essential cis-acting sequences. J Mol Biol, 304:753–763.
42.
Di SimoneP, Di LeonardoA, CostanzoG, MelfiR and SpinelliG. (2001). The sea urchin sns insulator blocks CMV enhancer following integration in human cells. Biochem Biophys Res Commun, 284:987–992.
43.
AcutoS, Di MarzoR, CalzolariR, BaiamonteE, MaggioA and SpinelliG. (2005). Functional characterization of the sea urchin sns chromatin insulator in erythroid cells. Blood Cells Mol Dis, 35:339–344.
44.
D'ApolitoD, BaiamonteE, BagliesiM, Di MarzoR, CalzolariR, FerroL, FrancoV, SpinelliG, MaggioA and AcutoS. (2009). The sea urchin sns5 insulator protects retroviral vectors from chromosomal position effects by maintaining active chromatin structure. Mol Ther, 17:1434–1441.
45.
WallaceJA and FelsenfeldG. (2007). We gather together: insulators and genome organization. Curr Opin Genet Dev, 17:400–407.
46.
Van BortleK and CorcesVG. (2013). The role of chromatin insulators in nuclear architecture and genome function. Curr Opin Genet Dev, 23:212–218.
47.
MoriguchiT, YuL, TakaiJ, HayashiM, SatohH, SuzukiM, OhnedaK and YamamotoM. (2015). The human GATA1 gene retains a 5′ insulator that maintains chromosomal architecture and GATA1 expression levels in splenic erythroblasts. Mol Cell Biol, 35:1825–1837.
48.
GolovninA, MelnikovaL, ShapovalovI, KostyuchenkoM and GeorgievP. (2015). EAST organizes Drosophila insulator proteins in the interchromosomal nuclear compartment and modulates CP190 binding to chromatin. PLoS One, 10:e0140991.
49.
FollenziA, AillesLE, BakovicS, GeunaM and NaldiniL. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet, 25:217–222.
50.
BaiamonteE, BagliesiM, MottaV, SpinaB and PecoraroA. (2014). Development of plasmids for quantitative detection of integrated lentiviral vectors and evaluation of culture time to perform vector titer by real-time quantitative polymerase chain reaction assay. Thalassemia Rep, 4:2189.
51.
CavalieriV and SpinelliG. (2015). Ectopic hbox12 expression evoked by histone deacetylase inhibition disrupts axial specification of the sea urchin embryo. PLoS One, 10:e0143860.
52.
MiccioA, PolettiV, TiboniF, RossiC, AntonelliA, MavilioF and FerrariG. (2011). The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene. PLoS One, 6:e27955.
53.
CattoglioC, PellinD, RizziE, MaruggiG, CortiG, MiselliF, SartoriD, GuffantiA, Di SerioC, et al. (2010). High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood, 116:5507–5517.
TolhuisB, PalstraRJ, SplinterE, GrosveldF and de LaatW. (2002). Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell, 10:1453–1465.
56.
FerraiuoloMA, RousseauM, MiyamotoC, ShenkerS, WangXQ, NadlerM, BlanchetteM and DostieJ. (2010). The three-dimensional architecture of Hox cluster silencing. Nucleic Acids Res, 38:7472–7484.
57.
RothSL, MalaniN and BushmanFD. (2011). Gammaretroviral integration into nucleosomal target DNA in vivo. J Virol, 85:7393–7401.
58.
Hacein-Bey-AbinaS, von KalleC, SchmidtM, Le DeistF, WulffraatN, McIntyreE, RadfordI, VillevalJL, FraserCC, Cavazzana-CalvoM and FischerA. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 348:255–256.
59.
ModlichU, NavarroS, ZychlinskiD, MaetzigT, KnoessS, BrugmanMH, SchambachA, CharrierS, GalyA, et al. (2009). Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther, 17:1919–1928.
60.
HanawaH, HargrovePW, KepesS, SrivastavaDK, NienhuisAW and PersonsDA. (2004). Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine betathalassemia. Blood, 104:2281–2290.
61.
MokHP, JavedS and LeverA. (2007). Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther, 14:741–751.
62.
SeniglF, AuxtM and HejnarJ. (2012). Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration site. Nucleic Acids Res, 40:5298–5312.
63.
PikaartMJ, Recillas-TargaF and FelsenfeldG. (1998). Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev, 12:2852–2862.
64.
ArumugamPI, UrbinatiF, VeluCS, HigashimotoT, GrimesHL and MalikP. (2009). The 3′ region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One, 4:e6995.
65.
BredaL, CasuC, GardenghiS, BianchiN, CartegniL, NarlaM, YazdanbakhshK, MussoM, ManwaniD, et al. (2012). Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients. PLoS One, 7:e32345.
66.
KoldejRM, CarneyG, WielgoszMM, ZhouS, ZhanJ, SorrentinoBP and NienhuisAW. (2013). Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors. Hum Gene Ther Clin Dev, 24:77–85.
67.
NielsenTT, JakobssonJ, RosenqvistN and LundbergC. (2009). Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants. BMC Biotechnol, 9:13.
68.
UrbinatiF, ArumugamP, HigashimotoT, PerumbetiA, MittsK, XiaP and MalikP. (2009). Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3′LTR. Mol Ther, 17:1527–1536.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
